NATIONAL
STOCK EXCHANGE OF INDIA LTD.
LISTING
CIRCULAR
Download Ref No. NSE/CML/14050
Ref No. NSE/LIST/C/2010/0107
Date: February 3, 2010
To all Members,
Sub: Listing of further issues of Glenmark Pharmaceuticals Ltd.
In pursuance of Regulation 3.1.1 of the National Stock Exchange (Capital Market) Trading Regulations Part A, it is hereby notified that the list of securities further admitted to dealings on the National Stock Exchange (Capital Market segment) with effect from February 4, 2010 the designated security codes thereof shall be as specified in Annexure.
In pursuance of Regulation 2.5.5 of the National Stock Exchange (Capital Market) Trading Regulations Part A, it is hereby notified that the respective lot sizes in respect of securities above shall be as specified in Annexure.
For the purpose of trading on the system, the security shall be identified only by its designated codes and trading in such securities shall be in such lot sizes as specified in Annexure.
This circular shall be effective from February 4, 2010.
For and on behalf of
National Stock Exchange of India Limited
Hari K
Asst. Vice President
ANNEXURE I
1.
Glenmark Pharmaceuticals Ltd.
|
Symbol |
GLENMARK |
|
Name of the Company |
Glenmark Pharmaceuticals Ltd. |
|
Series |
EQ |
|
ISIN |
INE935A01035 |
|
Face Value (In Rs.) |
1.00 |
|
Paid-up Value (In Rs.) |
1.00 |
|
Security Description |
Equity shares of Re.1/- each allotted to the employees of the company under ESOP 2003 |
|
No. of Securities |
59,200 |
|
Distinctive |
269701854 To 269761053 |
|
Market |
1 |
|
Pari Passu |
Yes |
|
Lock-in details |
Not Applicable. |